Chew...
then breathe!

The easy-to-take solution
for fast allergy relief

An allergy crisis will occur?

number 1

Chew 1-2 tablet(s)

1 to 2 tablets as necessary
(up to 10 tablets a day). Chew until the tablet(s) is (are) dissolved.
Ideally, do not take during mealtimes.

number 2

Wait for nearly
10-15 minutes

wait 10 minutes

Just 10 to 15 minutes to let
SniZtop® bioactives reaching
the allergens and acting
on the origin of your allergy.

number 3

Go & enjoy!

enjoy going outside

Thanks to SniZtop® rapid effect, you can continue your activities without any allergy symptoms. Red nose & red eyes over!

FAST-ACTING

Natural

CLINICALLY

Fast acting

NATURAL

Clinically
proven

EFFICACY

Year-round
efficacy

FAMILY

For adults
& children

The natural solution
derived from quail egg

SniZtop® bioactives are ovomucoïds, a glycoprotein derived from quail egg of a specific quail species. Investigation in quail eggs dates back in Europe to the early 1970's.

1700's

Interest in quail eggs in Asia

1970's

Quail egg benefits discovery on farmers raising quails (Dr. JC. Truffier)

1980's

Subsequent investigations in several human clinical trials (Dr. G. Bruttmann)

2000's

In vitro researches
Anti-allergic properties of ovomucoids

2010

STRAGEN proprietary manufacturing process Quail egg benefits into a tablet (GMP standards)

2014

STRAGEN Clinical Study Publication
Food Science & Nutrition

Tablet sniztop

SniZtop® offers all the quail egg benefits in 1 chewable tablet.

THE QUAIL EGG STORY

An innovative
mode of action

SniZtop® acts upstream of the allergic cascade by blocking allergens before they can activate the immune cells and therefore prevents the release of inflammatory mediators such as histamine.

SEE MORE ON VIMEO

Sniztop®
already approved by allergic persons

Market test performed on 70 French patients to evaluate
their feelings on perennial allergies.

already approved by allergic persons

I play tennis and spring is an important season for competitions. As soon as the days get warmer, I can feel my allergic reactions getting stronger, my eyes start to get sore, itchy and watery. I tried SniZtop® when I had a strong allergic reaction and I could feel an instant relief. It’s effective!

Romain, 14 yo - Saint-Etienne, France

quote quote

Sniztop®
the clinically proven solution

SniZtop® has been proven in 2 clinical studies.
More than 300 patients tested SniZtop® and the results are very conclusive.

Allergic rhinitis

Atopic dermatitis

The efficacy of SniZtop® on the reduction of rhinitis symptoms acutely experienced by subjects upon exposure to a cocktail of common outdoor and indoor allergens has been proven in a randomized, double-blind, crossover, placebo-controlled study (N=43).

Subjects were exposed (by inhalation) to a standardized allergenic challenge followed by the intake of 2 tablets of SniZtop® or placebo.
Measurements were taken every 15 min, for 2 hours.

Dust
mites

Trees
pollen

Grass
pollen

Dog & cat
dander

PRIMARY ENDPOINTS

Objective measurement
of the nasal congestion
(Peak Nasal Inspiratory Flow - PNIF)

SECONDARY ENDPOINTS

Subjective measurement
of nasal & eyes symptoms
(Visual analogue scale (VAS) score)

TERTIARY ENDPOINTS

Adverse Event Analysis

Fast-acting solution

SniZtop® provides allergy relief within 10 to 15 minutes

Comparison of Allergy Symptom Scores during the 120-minute follow-up vs placebo

All bothersome allergy symptoms were significantly reduced.
Subjects' perceived feeling of well-being was highly improved.

SniZtop® efficacy on the alleviation of eczematous lesions, itching sensation and on improvement within the quality of life in patients with Atopic Dermatitis (N=281).


Subjects were divided in 4 groups:


  • 28 subjects < 5 years old
  • 78 subjects betweeen 5 and 12 years old
  • 35 subjects between 12 and 18 years old
  • 140 subjects > 18 years old

Doses were from 1 to 4 tablets per day, and adjusted to the severity of clinical symptoms and the age of the patient.


The whole observation period lasted 8 weeks with follow up visit every 4 weeks.

PRIMARY ENDPOINTS

Surface of skin affected

SECONDARY ENDPOINTS

SCORAD score
(index dedicated to the diagnosis, treatment, and management
of Atopic Dermatitis)

TERTIARY ENDPOINTS

Itching sensation, sleep disorders,
oedema, redness, erosions
and lichenification

Skin lesions evolution between the 1st and 2nd visit

Sniztop® reduces itching sensation in 80% of patients within the first 4 weeks of treatment.



Quality of sleep has been consequently improved in 79% of young children (< 5 years old).